Company

PRIME Horizon2020

Research Services Fuerstenfeldbruck, De 1 employees

Employees: 1

www.prime-study.eu LinkedIn

PRIME Horizon2020 Overview

Headquarters: Fuerstenfeldbruck, De
Website: www.prime-study.eu
Industry: Research Services
Employees: 1
Founded: 2020
NAICS: Scientific Research and Development Services

Research and Development in the Physical, Engineering, and Life Sciences

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Keywords

research insulin Alzheimer's disease type 2 diabetes metabolic syndrome obesity obsessive compulsive disorder autism spectrum disorders genetics animal models dissemination epidemiology

About PRIME Horizon2020

PRIME is a European consortium of research institutes, medical centres, companies, and societal stakeholders that is funded through an EU Horizon 2020 grant. From 2020 – 2024, PRIME will aim to unravel the insulin-dependent mechanisms that underly both somatic conditions (i.e. type 2 diabetes, obesity, metabolic syndrome) and brain disorders (i.e. Alzheimer’s disease, obsessive-compulsive disorder, autism spectrum disorders). Until now, very little attention has been paid to the role of insulin signaling in brain disorders, and the overlap (or ‘multimorbidity’) with somatic conditions. Therefore, through PRIME, we aim to develop tools for improved diagnosis, clinical care and prevention of insulin-related lifespan multimorbidity.